• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU343415
Device Problem No Apparent Adverse Event (3189)
Patient Problem Aortic Dissection (2491)
Event Date 04/11/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Concomitant medical products: the patient¿s medications include; lasix, calcium, pradaxa, levothyroxine, protonix, valsartan and metoprolol.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the conformable gore® tag® thoracic endoprosthesis instructions for use, complications associated with the use of the gore® tag® thoracic endoprosthesis that may occur and/or require intervention include, but are not limited to persistent false lumen flow, dissection, perforation, or rupture of the aortic vessel & surrounding vasculature, and reoperation.
 
Event Description
On (b)(6) 2018, the patient underwent endovascular treatment of a thoracic aortic dissection with a conformable gore® tag® thoracic endoprosthesis.It was reported the left subclavian artery was intentionally covered during the initial implantation procedure.On (b)(6) 2018, follow-up imaging identified distal false lumen perfusion within the treated area with distal extension of the dissection.On (b)(6) 2018, an intervention was performed, whereby an additional tag device was implanted for distal extension.According to the report, the physician was unable to determine if the false lumen perfusion was resolved at the conclusion of the procedure.Reportedly, the physician will continue to monitor the patient.The patient was reported to have tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7478392
MDR Text Key107067657
Report Number2017233-2018-00251
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/16/2019
Device Catalogue NumberTGU343415
Device Lot Number15844816
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/16/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
Patient Weight50
-
-